Xanthogranulomatous Oophoritis: A Rare and Forgotten Entity
Abstract
Xanthogranulomatous oophoritis is a rare condition characterized by chronic inflammation and destruction of ovarian tissue. This case report describes a 25-year-old woman who presented with symptoms of bleeding, abdominal pain, and fever. Imaging revealed a tubo-ovarian mass, and during surgery, a pus-filled mass adhered to the right ovary was excised. Histopathological examination confirmed xanthogranulomatous oophoritis, and the pus culture showed the presence of coagulase- negative Staphylococcus aureus. This condition is often mistaken for ovarian malignancy and requires surgical removal of the affected ovary. Antibiotic therapy has not been successful in reducing the ovarian mass.
References
Kunakemakorn P, Ontai G, Balin H. Pelvic inflammatory pseudotumor: a case report. Am J Obstet Gynecol. 1976;126(2):286-7. [PubMed] [Google Scholar]
Punia RS, Aggarwal R, Amanjit, Mohan H. Xanthogranulomatous oophoritis and salpingitis: late sequelae of inadequately treated staphylococcal PID. Indian J Pathol Microbiol. 2003;46:80-1. [PubMed] [Google Scholar]
Shukla S, Pujani M, Singh SK, Pujani M. Xanthogranulomatous oophoritis associated with
primary infertility and endometriosis. Indian J Pathol Microbiol. 2010;53:197-8. [PubMed] [Google Scholar]
Chechia A, Bahri N, Felah R, Khaireddine A, Sakouhi M, Zakhama A. [Tubo-ovarian xanthogranulomatous inflammation. Report of a case]. Tunis Med. 1999;77:593-6. French. [PubMed] [Google Scholar]
Shashikala K, Sharmila PS, Sushma TA, Francis P. Ovarian haemangioma with synchronous xanthogranulomatous inflammation - a rare pathological finding. Int J Health Sci Res. 2013;5:116-9.
Altanis S, Raweily E, Katesmark M. Xanthogranulomatous endometritis and oophoritis secondary to diverticulitis. A rare cause of postmenopausal bleeding. J Obstet Gynaecol. 2007;27:746-7. [PubMed] [Google Scholar]
Kim SH, Kim SH, Yang DM, Kim KA. Unusual causes of tubo-ovarian abscess: CT and MR imaging findings. Radiographics. 2004;24:1575-89. [PubMed] [Google Scholar]
Abeysundara PK, Padumadasa GS, Tissera WG, Wijesinghe PS. Xanthogranulomatous salpingitis and oophoritis associated with endometriosis and uterine leiomyoma presenting as intestinal obstruction. J Obstet Gynaecol Res. 2012;38:1115-7. [PubMed] [Google Scholar]
Yener N, Ilter E, Midi A. Xanthogranulomatous salpingitis as a rare pathologic aspect of chronic active pelvic inflammatory disease. Indian J Pathol Microbiol. 2011;54:141-3. [PubMed]
Chou SC, Wang JS, Tseng HH. Malacoplakia of the ovary, fallopian tube and uterus: a case associated with diabetes mellitus. Pathol Int. 2002;52:789-93. [PubMed] [Google Scholar]
Chouairy CJ, Hajal EA, Nehme YA. Xanthogranulomatous oophoritis secondary to talcum powder. Case report and review of the literature. J Med Liban. 2012;60:169-
[PubMed] [Google Scholar ]
Singh UR, Revathi G, Gita R. Xanthogranulomatous oophoritis: an unusual complication of typhoid. J Obstet Gynaecol (Tokyo 1995). 1995;21:433-6. [PubMed] [Google Scholar]
Singh N, Tripathi R, Mala YM, Arora S. Xanthomatous oophoritis following uterine artery embolisation: successful conservative surgical management with favourable outcome. BMJ Case Rep. 2013;2013:bcr2013010184. [PubMed] [Google Scholar]
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Author's
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
